Novelion Therapeutics Inc. appointed Mark Corrigan to its board of directors.
Corrigan is the former CEO and president of Zalicus Inc. He currently serves on the board of Cardiome Pharma Corp. and on the supervisory board of Nabriva Therapeutics AG.
Novelion Therapeutics appoints board member
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Novelion Therapeutics appoints board member
- Author Ira Regmi
- Theme Healthcare & Pharmaceuticals
- Author
- Ira Regmi
- Theme
- Healthcare & Pharmaceuticals